UNSPSC 51342714: Peginterferon alfa-2a

Peginterferon alfa-2a is a form of recombinant interferon used alone or with other medicines to treat chronic hepatitis C.

UNSPSC 51342714 Peginterferon alfa-2a is a Commodity code, but the recent state and local opportunities do not support relevant procurement activity under it. The source records include one pharmaceutical-adjacent opportunity (an IFB for naloxone and drug deactivation systems issued by Seminole County, Florida) and several notices that are unrelated to the code's scope, including municipal vendor forums, trade show announcements, a county purchasing department relocation notice, and a multi-state cooperative RFP for generic pharmaceuticals and OTC products. The naloxone solicitation is distinct from peginterferon alfa-2a, which is a hepatitis C and chronic viral infection therapeutic, not an emergency medication or OTC product. The multi-state cooperative RFP targets generic pharmaceuticals and OTC items distributed through authorized wholesalers to state and local facilities, a different procurement channel and therapeutic category than specialty antivirals like peginterferon alfa-2a.

No evidence of recent state or local government solicitations specifically for peginterferon alfa-2a or other antiviral therapeutics at the commodity level appears in the source. The code shows no identifiable issuing bodies, geographic concentration, or representative opportunities that would warrant pursuit. State and local procurement of specialty pharmaceuticals like peginterferon alfa-2a typically flows through health departments, medicaid managed-care programs, and hospital systems via formulary or disease-management contracts at higher tier codes rather than through commodity-level spot buys. Activity under this code warrants watch only; pursue opportunities would be better identified through state Medicaid procurement offices or regional health authority sourcing channels.